The intestinal microbiota is composed of diverse microbial species that provide numerous benefits to their hosts 1 . However, the micro biota can also contain pathobionts that can cause disease if not pro perly constrained 1, 2 . A major mechanism constraining pathobionts is believed to be competition or suppression by the healthy micro biota 1 . Indeed, disruption of the healthy microbiota (for example, by antibiotic treatment) can elicit pathobiont virulence and disease 1, [3] [4] [5] [6] . Although pathobionts are believed to contribute to numerous disease states [7] [8] [9] [10] [11] , it has been challenging to identify the causal molecular mechanisms that are responsible for disease in vivo [12] [13] [14] [15] .
A key orchestrator of innate immune responses are inflammasomes, multiprotein complexes that detect infection in the cytosol and are required for activation of the caspase1 protease, and downstream secretion of two of its substrates, the proinflammatory cytokines interleukin1β (IL1β) and IL18 (ref. 16 ). Several distinct inflamma somes have been described, including the Naip5Nlrc4 inflammasome, which detects flagellin proteins from diverse bacteria 17, 18 . Recently, several reports have established a protective role for inflammasomes in regulating microbiota composition and tissue reparative and regen erative responses to intestinal injury 13, [19] [20] [21] [22] . Although inflammasome responses in these models are protective against disease, it is also well recognized that excessive inflammation has the potential to be pathological. However, a potential pathological role of inflamma some activation in response to a disrupted intestinal flora has not yet been investigated.
Here we find that disruption of the microbiota by antibiotics predis poses mice to a lethal sepsislike disease upon intestinal injury. Death is associated with the systemic infection with a multidrugresistant E. coli pathobiont and requires activation of the Naip5Nlrc4 inflam masome. In accordance with Koch's postulates, intravenous injection of the E. coli pathobiont into normal mice recapitulates the rapidly fatal Naip5Nlrc4-dependent sepsis. Our results reveal a molecular mechanism by which disruptions of intestinal homeostasis can result in aberrant pathobiontinduced innate immune signaling and rapid sepsislike death.
RESULTS

Antibiotics and intestinal injury results in sepsis
To study the innate immune response to a disrupted intestinal micro biota, we established a disease model that couples antibiotic treat ment with dextran sulfate sodium (DSS)induced intestinal injury. DSS is toxic to colonic epithelial cells and typically causes a colitis like disease 23 characterized by severe weight loss, colonic bleeding and colonic shortening ( Supplementary Fig. 1a,b) . We wanted to understand how antibioticinduced disruption of the microbiota (dys biosis) would influence DSSinduced disease. Oral administration of a broadspectrum antibiotic cocktail composed of ampicillin, vancomy cin, neomycin and metronidazole (AVNM) to colonyborn C57BL/6 wildtype mice resulted in a change in the microbiota composition and a reduction in the amount of 16S rDNA gene copy number along the intestinal tract ( Supplementary Fig. 1c-e) . After this initial treat ment, we gave the mice AVNM plus 5% DSS and monitored survival. Consistent with previous reports 24 , mice treated with AVNM showed faster death kinetics in response to DSS compared to wildtype lit termates that received DSS only ( Fig. 1a and Supplementary Fig. 1f) . Notably, ampicillin alone was sufficient to increase mortality in response to DSS treatment ( Supplementary Fig. 1g,h ). In contrast, mice treated with the broadspectrum antibiotic streptomycin and DSS showed similar death kinetics to DSStreated littermates that were not treated with antibiotics (Fig. 1b) .
Although DSS typically induces colitis, we found that AVNM plus DSStreated colonyborn mice did not show the hallmark symptoms of colitis (for example, weight loss, colonic inflammation and short ening and poor stool pellet formation, as seen in mice treated with DSS alone; Fig. 1c -e and data not shown). Rather, AVNM plus DSS treated mice showed bleeding in the small intestine and hypothermia (Fig. 1f,g and Supplementary Fig. 2a) , as well as multiple organ dam age and elevated serum concentrations of proinflammatory cytokines including tumor necrosis factorα (TNFα) and IL6 ( Fig. 1h and data not shown). These results suggest that AVNMinduced changes to the microbiota trigger a systemic disease distinct from colitis in response to intestinal injury. Hypothermia and multiple organ damage are asso ciated with sepsis in mice 25, 26 . In addition, we found that antibiotic treated mice showed significantly higher colonization of culturable bacteria in the lung (P < 0.05) and the liver (P < 0.05) compared to nonantibiotictreated mice ( Fig. 1i and Supplementary Fig. 2b,c) .
To determine whether the sepsislike disease was specific to mice from our facility, we analyzed disease progression in AVNM plus DSStreated C57BL/6 specific pathogen-free (SPF) mice from Jackson Laboratory (Jax mice) and Taconic Farms (Taconic mice). AVNM plus DSStreated Taconic mice developed symptoms associated with a sepsislike dis ease, characterized by hypothermia, and increased mortality compared to Taconic mice treated with only DSS. Furthermore, AVNM attenu ated DSSinduced colitis symptoms in Taconic mice ( Supplementary  Fig. 3a,b and data not shown). In contrast, disease in AVNM plus DSS treated Jax mice appeared to develop similarly to that in Jax mice treated with only DSS (Supplementary Fig. 3c -e and data not shown). Thus, it seems that SPF mice from different facilities show distinct disease symptoms in response to treatment with AVNM plus DSS.
Antibiotic-induced expansion of drug-resistant E. coli Several nonexclusive models could explain how alterations in the microbiota can trigger disease. For example, antibiotic treatment could eliminate members of the microbiota that elicit protective host responses 24 . In addition, antibiotics could result in the overgrowth of AVNMresistant pathobionts. Consistent with the latter possibi lity, after 7 d of AVNM treatment, colonyborn wildtype mice har bored an expanded population of AVNMresistant bacteria along the intestinal tract (Fig. 2a) . We observed a similar expansion of an AVNMresistant population in Taconic mice but no detectable levels of culturable AVNMresistant bacteria in Jax mice ( Supplementary  Fig. 3 ). Furthermore, we found that the AVNMresistant bacteria colonized extraintestinal tissues of colonyborn wildtype mice treated with AVNM plus DSS (Fig. 2b,c and Supplementary Fig. 2) . Thus, sepsislike disease correlated with the intestinal expansion and extraintestinal colonization of AVNMresistant bacteria.
We obtained an AVNMresistant isolate from our mice that we identified as an E. coli O21:H+ by16S rDNA sequencing, biochemi cal characterization and serotyping (Fig. 2d,e antibiotic treatment is consistent with previous reports 27 . AVNM resistant E. coli was also recovered from the lung, liver, spleen and kidney of AVNM plus DSStreated colonyborn mice ( Fig. 2f and Supplementary Fig. 2e,f) . To determine whether E. coli was the predominant systemic AVNMresistant species in our mice, we performed 16S rDNA cloning and sequencing analyses of livers and spleens from AVNM plus DSStreated colonyborn mice. Although this approach identified clones representing multiple taxa, Escherichia was the most abundant taxon identified, consistent with our culturing experiments. In addition, E. coli was the only taxon recovered from all tissues from AVNM plus DSStreated mice analyzed (data not shown). We also identified AVNMresistant E. coli in the intestines of Taconic mice (Supplementary Fig. 3 ). E. coli O21:H+ was present in the microbiota of unmanipulated mice (Fig. 2e) but was not abundant, suggesting it was not able to compete efficiently for intestinal colonization with other members of the flora in the absence of antibiotics. Consistent with this hypothesis, we found that 1 week after cessation of AVNM treatment the aber rant expansion of E. coli O21:H+ was suppressed ( Supplementary  Fig. 4a ), and such mice no longer developed sepsis in response to DSS (Supplementary Fig. 4b,c) .
As streptomycintreated mice did not show rapid sepsislike death in response to DSS (Fig. 1b) , we hypothesized that our AVNM resistant E. coli isolate is sensitive to streptomycin. Indeed, we found that our E. coli O21:H+ isolate is sensitive to streptomycin and is eliminated from mice by streptomycin treatment (Fig. 2d,g ). Taken together, our data clearly demonstrate that the sensitivity of mice to AVNM plus DSS and development of sepsis is associated with intes tinal overgrowth and extraintestinal colonization of AVNMresistant E. coli O21:H+. For survival, P = 0.0236 by log-rank analysis. Data represent two combined experiments; Jax single-housed (n = 11); Jax co-housed (n = 11); CB co-housed (n = 11); DSS only (n = 5). For a-c, e and f, red horizontal dashed line represents the limit of detection, and black filled circles represent individual mice below the limit of detection. ND, not detected.
Because Jax mice do not seem to be colonized with AVNMresistant E. coli O21:H+, we could use them to determine whether this bac terium and its associated disease phenotype are transmissible. We housed Jax mice with colonyborn mice and treated them with AVNM for 7 d, after which the Jax mice showed AVNMresistant E. coli colonization levels comparable to those in the colonyborn mice. In contrast, singlehoused Jax mice had no detectable AVNMresistant E. coli (Fig. 2h) . Upon induction of intestinal injury by DSS, AVNM treated Jax mice housed with colonyborn mice showed symptoms of sepsislike disease and mortality, similar to colonyborn mice, and unlike singlehoused Jax mice (Fig. 2i) . These results indicate that E. coli O21:H+ and its associated sepsis phenotype are transmissible.
Systemic E. coli infection is sufficient to induce sepsis To determine whether our E. coli O21:H+ isolate is sufficient to cause sepsislike disease in wildtype mice, we orally infected AVNMtreated Jax mice with E. coli O21:H+. Oral administration of E. coli O21:H+ to AVNMtreated Jax mice resulted in high levels of intestinal colonization (Supplementary Fig. 4d ). Furthermore, AVNM plus DSStreated, E. coli O21:H+-colonized Jax mice developed hypothermia that was associated with reduced colitis symptoms compared to AVNM plus DSStreated Jax mice that received an oral PBS challenge (Supplementary Fig. 4e ).
To determine whether the E. coli O21:H+ isolate is sufficient to cause disease in wildtype mice with a normal (non-antibiotic treated) microbiota, we intravenously injected normal colonyborn and Jax C57BL/6 mice with live or dead E. coli O21:H+ and moni tored disease. Mice were highly susceptible to a systemic challenge of live but not heatkilled bacteria, as indicated by increased mortality (Fig. 3a) . In addition, systemic live E. coli O21:H+ infection was suf ficient to recapitulate the specific pathology associated with AVNM plus DSS treatment (Fig. 3b,c) . Furthermore, live E. coli-infected mice showed tissue colonization patterns and levels similar to those observed in AVNM plus DSStreated wildtype mice (Figs. 1i, and 3d and Supplementary Fig. 2b,c) . Thus, in fulfillment of Koch's pos tulates, a live systemic infection with E. coli O21:H+ is sufficient to recapitulate the mortality and morbidity associated with AVNM plus DSSinduced sepsis.
E. coli O21:H+ harbors virulence factors E. coli O21 strains have been isolated from patients with extraintes tinal infections including bacteremia and sepsis [28] [29] [30] [31] [32] . We therefore hypothesized that the E. coli pathobiont encodes virulence factors mediating its pathogenicity in wildtype mice. Consistent with this hypothesis, disease was attenuated in mice intravenously infected with a nonpathogenic E. coli K12 strain (MG1655) as compared to our E. coli O21:H+ isolate (Fig. 3e,f) , suggesting that detection of viable, nonpathogenic strains of E. coli by the immune system 33 is not suf ficient to trigger sepsislike disease in wildtype mice.
To identify virulenceassociated determinants, we sequenced the genome of our E. coli O21:H+ isolate and aligned the reads to reference E. coli genomes (Supplementary Table 1 ). The fliC gene, encoding flagellin (H antigen), was most similar to that of H21 iso lates (Supplementary Fig. 5a ). In addition, alignment to the E. coli O157:H7 strain Sakai reference genome revealed that our O21:H+ isolate harbors a cluster of genes with similarity to the ETT2 type III secretion system 34 (Supplementary Fig. 5b ). Many septicemic E. coli isolates encode a unique version of the ETT2 gene cluster called ETT2 sepsis 35 that contains a large deletion in the eiv gene cluster (clus ter E in Supplementary Fig. 5b ), creating deletions and truncations for the majority of eiv genes 35 . Despite this, ETT2 sepsis is essential for sepsis pathogenesis, as deletion of genes within the ETT2 sepsis gene cluster render septicemic E. coli avirulent 35 . Notably, we were unable to align the genomic content of the E. coli O21:H+ genome to the 8.7kb region of the ETT2 gene cluster that contains the eiv genes, suggesting that E. coli O21:H+ harbors a form of the ETT2 sepsis gene cluster (Supplementary Fig. 5b) .
We also found that E. coli O21:H+ encodes additional factors associated with extraintestinal E. coli clinical isolates including those important for adhesion (papC, the fim gene cluster and the pil gene cluster), internalization (the csg genes) and iron acquisition (enterobactin and ferrichrome gene clusters) [35] [36] [37] [38] [39] [40] [41] [42] [43] . The genome also encodes malX (marker for pathogenicityassociated island from strain CFT073) 38 .
Naip5-Nlrc4 inflammasome mediates AVNM/DSS-induced sepsis
As pathogenic E. coli were previously reported to activate inflamma somes containing Naip and Nlrc4 proteins 44, 45 , we hypothesized that the Naip5Nlrc4 inflammasome might mediate disease in our sepsis model. Indeed, we found AVNM plus DSSinduced disease progres sion was highly attenuated in Nlrc4 −/− ;Naip5 −/− mice (Fig. 4a-e) . Notably, AVNMtreated Nlrc4 −/− Naip5 −/− mutant mice showed simi lar levels of AVNMresistant E. coli overgrowth in the intestinal tract as wildtype fostermates (wildtype pups that nursed on the mother of mutant pups) before DSS treatment, implying that inflammasome deficiency did not exert its protective effects by modulating bacte rial growth (Fig. 4f and Supplementary Fig. 6a,b) . Moreover, the organs of AVNMplus DSStreated Nlrc4 −/− ;Naip5 −/− mice were colo nized with similar levels of AVNMresistant E. coli as wildtype mice ( Fig. 4g and Supplementary Fig. 6c,d) . These data indicate that the absence of Naip5Nlrc4 function protects AVNM plus DSStreated mice from developing sepsis at a step after extraintestinal dissemina tion of E. coli O21:H+. As Nlrc4 −/− ;Naip5 −/− mice eventually succumb to AVNM plus DSSinduced sepsis, it is likely that additional host factors also contribute to disease.
The Naip5Nlrc4 inflammasome generally detects flagellin trans located to the host cell cytosol via type III or IV secretion systems 44 . Because E. coli O21:H+ encodes a type III secretion system and a functional flagellin (FliC) (Fig. 5a and Supplementary Fig. 5 ) simi lar to that of other pathogenic E. coli species, we hypothesized that the cytosolic presence of flagellin from this pathobiont can activate the Naip5Nlrc4 inflammasome. We tested this hypothesis using a previously described retroviral 'lethality' assay 44 in which flagellin is expressed from a retroviral promoter directly in host cells, allowing for analysis of the effects of flagellin in the absence of other bac terial factors. We retrovirally transduced wildtype, Nlrc4 −/− and Naip5 −/− bone marrow-derived macrophages with fliCIRESGFP, control GFP or control Legionella pneumophila flagellin (flaA-IRES GFP). Activation of Naip5Nlrc4 by flagellin results in cell death, as indicated by the loss of GFPpositive cells. As previously reported 46 , cells expressing L. pneumophila flaA-IRESGFP could only be recov ered from Nlrc4 −/− macrophages (Fig. 5b,c) . Detection of FlaA by Naip6 probably accounts for the residual responsiveness of Naip5 −/− cells. However, we were able to recover cells expressing E. coli O21:H+ fliCIRESGFP from both Nlrc4 −/− and Naip5 −/− macro phages but not wildtype macrophages (Fig. 5b,c) . These data sug gest that cytosolic flagellin derived from E. coli O21:H+ activates the Naip5Nlrc4 inflammasome and triggers host cell death. 
Naip5-Nlrc4 inflammasome reduces host tolerance of E. coli
Nlrc4
-/-;Naip5 Naip5Nlrc4 function (P = 0.0001) ( Fig. 6a and Supplementary  Fig. 7a,b) . The absence of Naip5Nlrc4 function also alleviated the pathologies associated with E. coli O21:H+ infection, including small intestinal bleeding, multiple organ damage and hypothermia ( Fig. 6b-d) . Furthermore, E. coli O21:H+ infection was attenu ated in Casp1 −/− (caspase 1 deficient) and Il1b −/− mice ( Fig. 6e and Supplementary Fig. 7c,d) . Additionally, systemic administration of IL1 receptor-specific antibody protected mice from AVNM plus DSSinduced disease (Fig. 6f) . Thus, the absence of IL1β is suffi cient to protect mice from a systemic inflammatory response induced by a systemic E. coli O21:H+ infection ( Fig. 6e and Supplementary  Fig. 7d ). Taken together, our data clearly indicate that Naip5Nlrc4 inflammasome signaling through IL1β in response to a systemic E. coli O21:H+ infection leads to sepsis. The greater susceptibility of wildtype (as compared to Nlrc4 −/− ; Naip5 −/− ) mice to E. coli O21:H+ infection was not associated with higher levels of extraintestinal bacterial colonization (Fig. 6g) . In fact, coloniza tion levels were similar in both genotypes. Thus, we conclude that mice lacking Naip5Nlrc4 fare better in response to a systemic E. coli O21:H+ infection because they show increased tolerance of the infection 47 rather than because of negative effects on pathogen fitness.
DISCUSSION
We describe a mouse model of sepsis triggered by dysbiosis and intes tinal injury. This model resembles the clinically significant sepsis that is a major problem in human patients undergoing combination thera pies involving antibiotics and cytotoxic treatments that damage the gut epithelium 48 . Consistent with the defining features of sepsis, we found that disease in AVNM plus DSStreated mice is character ized by systemic dissemination of bacteria, multiple organ damage and systemic responses such as hypothermia. A key conclusion of our study is that sepsis in our AVNM plus DSStreated mice is due to inflammasome activation by a specific multidrugresistant E. coli O21:H+ pathobiont. This pathobiont exists in the normal unma nipulated flora but expands dramatically in the gut upon antibiotic treatment and reaches systemic sites following DSSinduced intestinal injury (Supplementary Fig. 7e ). Systemic inoculation of this patho biont is sufficient to induce sepsislike disease. Similar to our findings, a previous report demonstrated that anti biotic pretreatment rendered mice more susceptible (increased mor tality) to DSS treatment 24 . However, this report proposed that disease in AVNM plus DSStreated mice is not associated with systemic spread of bacteria but is instead due to a failure to receive appropriate Tolllike receptor-dependent signals needed to repair gut epithelial injury. Consistent with this interpretation, it was found that disease could be alleviated by the oral administration of lipopolysaccharide (LPS), suggesting that Tolllike receptor signaling has a key protective role 24 . In contrast, in our model, mice given AVNM plus DSS showed symptoms of sepsis, not colitis, and oral administration of LPS was not sufficient to prevent sepsis (Supplementary Fig. 2d) . Indeed, dysbiosis in the AVNMplusDSS model may both reduce the levels of beneficial microbes and result in an expansion of pathobionts. The apparent discrepancy between our work and the prior study 24 may be explained by differences in microbial flora in the mice, as well as by methodological differences. For example, the previous study admin istered drinking water supplemented with 2% DSS to mice for a total of 7 d, which produces milder damage that mice are able to repair. In our model, we used a continuous dose (until the end of the experi ment) of 5% DSS. Nevertheless, as systemic infection of normal mice with E. coli O21:H+ is sufficient to recapitulate the AVNMplusDSS disease model, we favor the hypothesis that pathology in our mice is driven primarily by an E. coli pathobiont.
Previous studies have demonstrated a protective role for the inflam masome in mediating pathogen resistance 45, 49 and in inducing tis sue repair 20, 21 . Our study demonstrates that excessive or systemic inflammasomemediated recognition of a bacterium can lead to pathology and death. In our model, inflammasome activation results in IL1β-driven immunopathology that the host cannot tolerate (Supplementary Fig. 7) . The dependence on IL1β distinguishes our sepsis model from others, including LPS endotoxemia ( Supplementary  Fig. 7 ) [50] [51] [52] . Blockade of IL1 signaling has long been considered a potential therapeutic treatment for human sepsis, but it has met with little success in clinical trials 53, 54 . This is probably because sepsis is a complex disease involving diverse microbes and host immune path ways. Our results highlight the importance of experimentally defin ing the relevant pathogenic pathways for different microbial causes of sepsis and identifying the causative agents of sepsis in humans.
Antibioticresistant E. coli present a challenge to antimicrobial medical interventions 4 . Our finding that mice lacking inflamma some components show increased tolerance of systemic E. coli infec tion may have key therapeutic implications. Tolerance (not to be confused with immunological tolerance) is a defense strategy that allows a host to endure an infection without influencing microbial load 47, 55 . Tolerance contrasts with resistance, which protects a host by decreasing pathogen burden 47, 55 . In contrast to antimicrobials (which work to decrease pathogen burden), therapeutic interven tions to increase tolerance could protect the host without imposing negative effects on pathogen fitness. A key benefit of therapeutic modulation of host tolerance pathways is that pathogens are not predicted to evolve antagonistic traits to such therapeutics 47, 56, 57 . Thus, we propose that the inflammasome may be an alternative therapeutic target for patients showing pathology from antibiotic resistant pathobionts.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/. 
ONLINE METHODS
Mice. Naip5 −/− mice were generated as described previously 44 . Nlrc4 −/− mice were from S. Mariathasan and V. Dixit 58 . We crossed Naip5 −/− and Nlrc4 −/− mice to each other to generate doubleknockout mice. Casp1 −/− mice were a gift from A. Van der Velden and M. Starnbach 59 . Il1b −/− mice were from the Zychlinsky lab at Max Planck Institute. Genetargeted mice were on a C57BL/6 background. Wildtype C57BL/6 mice were originally obtained from the Jackson Laboratories, but all colonyborn mice used were bred in our mouse facility for at least ten generations. All mice were specific pathogen free, maintained under a 12h lightdark cycle (7 a.m. to 7 p.m.) and given a standard chow diet (Harlan irradiated laboratory animal diet) ad libitum. For experiments involving littermate mice, we crossed Naip5 +/− ;Nlrc4 +/− mice to generate Naip5 −/− ;Nlrc4 −/− and Naip5 +/+ ;Nlrc4 +/+ littermates. For fostermate mice, we placed wildtype pups with the mutant litter within 48 h of birth to nurse on the Naip5 −/− ;Nlrc4 −/− mother. Pups were weaned at 21 d of age. Mouse experiments were approved by the University of California-Berkeley Animal Care and Use Committee.
Survival assays. We used time to moribund for all survival assays. We identified moribund mice as those mice showing ataxia severe enough such that the mice could not recover (unable to move when gently touched or experiencing trouble selfcorrecting when placed on their sides). Moribund mice were euthanized in compliance with the Animal Care and Use Committee at the University of California-Berkeley.
DSS colitis model.
We transferred 6weekold littermates to new cages and gave them drinking water supplemented with 5% DSS (w/v) (molecular weight 36,000-50,000 Da; MP Biomedicals) continuously for the duration of the experiment. We measured disease severity by monitoring survival (time to moribund) and weight daily, and colon length was measured at 6 d after DSS treatment initiation.
Antibiotic/DSS sepsis model. At 5 weeks of age, we transferred littermates or fostermates to new cages and gave them drinking water supplemented with a combination of ampicillin (1 g L −1 ), neomycin (1 g L −1 ), metronidazole (1 g L −1 ) and vancomycin (0.5 g L −1 ), ampicillin only (1 g L −1 ) or streptomycin only (2 g L −1 ) for 7-10 d (SigmaAldrich). After this initial antibiotic treatment, we gave mice drinking water supplemented with the appropriate antibiotic at the above mentioned concentration plus 5% DSS (w/v) continuously over the course of the experiment. We monitored mice for signs of disease including weight loss and colonic shortening as described above, rectal temperature and serum analysis of organ damage as well as bacterial extraintestinal tissue colonization. For administration of LPS plus AVNM plus DSS, we gave mice drinking water supplemented with AVNM plus 5% DSS and 10 µg ml −1 LPS O55:B5 (Sigma) after an initial 10 d AVNM treatment.
E. coli in vivo infections.
We grew E. coli overnight in LB medium shaking at 37 °C. We transferred agematched female mice to new cages and injected them intravenously with 5 × 10 8 , 7.5 × 10 8 or 1 × 10 9 live bacteria in PBS and gave them food and water ad libitum. We monitored body temperature and survival (time to moribund). For injections with dead bacteria, we prepared inoculums at the appropriate concentration in PBS and incubated at 65 °C for 30 min to heatkill the bacteria. For E. coli K12 infections, we grew E. coli overnight in LB medium shaking at 37 °C. We transferred agematched female mice to new cages and injected them intravenously with 5 × 10 8 bacteria in PBS and gave them food and water ad libitum.
Body temperature. We monitored body temperature using a rectal probe and microtherma thermometer (Braintree Scientific). We lubricated the probe with a waterbased lubricant (Astroglide) before use. Serum analysis. We euthanized mice and obtained blood by cardiac puncture at the indicated time points. We then aliquoted blood into BD serum separator tubes, incubated at room temperature for 20 min and centrifuged at 2.6 r.p.m. for 20 min. We stored serum at −80 °C until analysis. BUN, CPK, AST and ALT measurements were done by IDEXX Laboratories.
Bacterial culturing. For compositional analysis of the intestinal tract and extraintestinal tissues, we harvested whole tissues and homogenized them using a Polytron PT2100 homogenizer at 17,000 r.p.m. (Kinematica) in sterile thio glycolate medium. We then serially diluted the homogenate and plated on LB agar and Schaedler agar supplemented with 5% defibrinated sheep blood plates and grew at 37 °C aerobically and anaerobically for 24 h. We counted bacterial colonies and then separated on the basis of colony appearance and performed colony 16S rDNA PCR and sequencing (see below).
For cultivation of Enterobacteriales species, we harvested and homoge nized intestinal and extraintestinal tissues from mice treated with AVNM plus DSS as described above. We then serially diluted the homogenates and plated them on bacterial media that support the growth of Enterobacteriales, including LB, Maconkey and EMB. We then incubated the plates aerobi cally at 37 °C for 24 h, after which we counted colonies, classified on the basis of colony appearance and subjected them to 16S rDNA colony PCR and sequencing (see below). We then tested isolates for antibiotic susceptibil ity (see below).
For CFU analysis of E. coli in mice infected with E. coli O21:H+, we harvested and homogenized intestinal and extraintestinal organs in sterile PBS, serially diluted and plated the homogenates on EMB or LB plates containing AVNM and incubated them at 37 °C for 24 h.
Colony PCR. We resuspended colonies in sterile PBS and boiled them for 10 min at 100 °C. We used this directly for PCR analysis with the universal bacterial primers 27F (5′AGAGTTTGATCCTGGCTCAG3′) and 1492R (5′GGTTACCTTGTTACGACTT3′) 60 . We performed PCR on a BioRad iCycler with the following conditions: 95 °C (5 min), 30 cycles of 95 °C (30 s), annealing at 51 °C (1 min), 72 °C (2 min) and final extension at 72 °C (10 min). Reactions were then subjected to a PCR cleanup using the QIAquick PCR Purification Kit (Qiagen) and sequenced using the 1492R primer (Elim Biopharm). We classified the sequences using the Michigan State University Ribosomal Database Project classifier function (http://rdp.cme.msu.edu/). Antibiotic susceptibility assays. We determined E. coli O21:H+ susceptibi lity to AVNM and streptomycin using a disc diffusion assay. We inoculated liquid cultures with E. coli and grew them at 37 °C with shaking overnight. We placed aliquots of cultures onto LB agar plates and 6mm Whatman discs loaded with the appropriate antibiotic onto the agar. We incubated plates overnight at 37 °C and measured the zone of bacterial growth inhibition. Antibiotic susceptibility profiling of the isolate was also performed by the Clinical Microbiology Laboratory at Kaiser Permanente. E. coli DH5α was used as a control.
16S rDNA quantitative PCR analyses. We gave mice regular drinking water or drinking water supplemented with AVNM for 7-10 d. We then harvested intestinal tissues, snap froze them in liquid nitrogen and stored them at −80 °C before analysis. We extracted DNA using the Qiagen Stool Kit per manufac turer's instructions with a beadbeating step. Specifically, we put whole tis sues into Lysing Matrix E tubes (MP Biomedicals) with 1.4 ml of buffer ASL and subjected to three cycles of shaking for 3 min using a Vortex Genie 2. We placed samples on ice for 3 min in between cycles. We extracted DNA from the resulting supernatants per the manufacturer's protocol. We quantified purified DNA on a Nanodrop 1000 (Thermo Scientific) and then performed quantita tive PCR assays on the Step One Plus RT PCR system (Applied Biosystems) with the iTaq SYBR Green Supermix with Rox reagent (BioRad). We nor malized 16S gene copy numbers to Rps17 (mouse). We used the following primer sequences: mouse Rps17F (5′CGCCATTATCCCCAGCAAG3′) and Rps17R (5′TGTCGGGATCCACCTCAATG3′); universal bacte rial 16S rDNA uniF340 (5′ACTCCTACGGGAGGCAGCAGT3′) and uniR514 (5′ATTACCGCGGCTGCTGGC3′) 61 ; Enterobacteriaceae 16S rDNA-specific 515F (5′GTGCCAGCMGCCGCGGTAA3′) and 826R (5′GCCTCAAGGGCACAACCTCCAAG3′) 61 ; Bacteroides 16S rDNAspecific BactF285 (5′GGTTCTGAGAGGAGGTCCC3′) and UniR338 (5′GCTGCCTCCCGTAGGAGT3′) 61 ; Actinobacteria 16S rDNAspecific Actino235F (5′CGCGGCCTATCAGCTTGTTG3′) and Eub518R (5′ATTACCGCGGCTGCTGG3′) 62 .
